Utah Life Sciences News & Events

BREAKTHROUGH DEVICE DESIGNATION: UNDERSTANDING REGULATORY AND REIMBURSEMENT IMPLICATIONS WEBINAR

August 4, 2021
12:00 pm
Virtual

The Breakthrough Devices Program is an FDA initiative to promote patient access to innovative new therapies and diagnostics for life-threatening or irreversibly debilitating diseases or conditions. Join AdvaMed for a timely webinar on the topic. There is no cost for AdvaMed members and government employees.

Recent News

EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections
Merit Medical Shareholders Elect Silvia M. Perez as New Director
EVŌQ Bio Completes Successful Pre-Investigational New Drug Meeting With FDA for Development of Inhaled Therapeutic to Treat Pulmonary Infections
Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer’s Disease at Discovery Europe 2024